Aprovel®Tablet 150mg, 300mg

Ingredient

[Aprovel®Tablet 150mg]
Irbesartan 150mg, 

 

[Aprovel®Tablet 300mg]
Irbesartan 300mg

Content

[Aprovel®Tablet 150mg]
Oval film-coated tablet with a convex shape on both sides, with white or nearly white color. One side is engraved with a heart shape, and the other side is marked with the number “2872”

 

[Aprovel®Tablet 300mg]
Oval film-coated tablet with a convex shape on both sides, with white or nearly white color. One side is engraved with a heart shape, and the other side is marked with the number “2873”

Indication

1. Essential Hypertension
2. Treatment of Hypertensive Nephropathy in Patients with Stage 2 Diabetes and Hypertension

Arixtra Inj.

Ingredient

Fondaparinux Sodium

Content

2.5mg/0.5ml (pre-filled syringe)

Indication

1) Prophylaxis of venous thromboembolism in patients undergoing major orthopedic surgery of the lower limb, such as hip fracture surgery, knee surgery, or hip replacement surgery
2) Prophylaxis of venous thromboembolism in patients underwent abdominal surgery, such as abdominal cancer surgery who are deemed to have a high risk of thromboembolic complications
3) Prophylaxis of venous thromboembolism in patients with limited mobility due to acute diseases such as heart failure (NYHA class Ⅲ or Ⅳ), acute respiratory disease, acute infection or inflammatory disease and medical patients who are deemed to have a high risk of venous thromboembolism
4) Treatment of unstable angina or non-ST segment elevation myocardial infarction (UA/NSTEMI) in patients who are not covered by emergency invasive management (Percutaneous Coronary Intervention(PCI) within 120 minutes)
5) Treatment of ST segment elevation myocardial infarction (STEMI) in patients who are being treated with thrombolytic agents or initially not receiving other forms of reperfusion therapy

AVAXIM 160U ADULT INJ.

Ingredient

Hepatitis A virus, GBM strain (inactivated)1, 2……160 EU

Content

Indication

active immunisation against hepatitis A infection in adults and
children 2 years and over

Calcort Tab. 6mg

Ingredient

Deflazacort (Micronized)

Content

6mg

Indication

1) rheumatoid disorders and connective tissue diseases: Maintenance therapy and treatment of acute exacerbation of psoriatic arthritis and rheumatoid arthritis, which are ineffective with general treatment, polymyalgia rheumatic, acute rheumatic fever, systemic lupus erythematosus, cranial arteritis, and Wegener’s granulomatosis
2) skin diseases: Pemphigus, bullous pemphigoid, exfoliative dermatitis, erythema multiforme, erythema nodosum, and severe psoriasis
3) allergic diseases: Bronchial asthma, which is not effective with general treatment
4) respiratory diseases: Sarcoidosis with pulmonary infiltration, extrinsic allergic alveolitis (silicosis due to organic dust), desquamative interstitial pneumonia (idiopathic pulmonary fibrosis)
5) ophthalmic diseases: Choroiditis, chorioretinitis, iritis, and iridocyciltis
6) hematopoietic system diseases: Idiopathic thrombocytopenia, hemolytic anemia, lymphatic leukemia, and lymphoma
7) gastrointestinal diseases: Ulcerative colitis and Crohn’s disease
8) liver disease: Chronic active hepatitis (autoimmune hepatitis)
9) kidney disease: Nephrotic syndrome

Celex

Ingredient

Celecoxib

Content

200mg

Indication

Celecoxib is indicated in adults for the symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.

Cleocin-T Topical soln. 1%

Ingredient

Clindamycin Phosphate

Content

1.188g/100ml (1g as Clindamycin)

Indication

Effective species: Propionibacterium acnes
Indication: Treatment of acne vulgaris

Coaprovel®Tablet 150/12.5mg, 300/12.5mg

Ingredient

[Coaprovel®Tablet 150/12.5mg]
Hydrocholorothiazide 12.5mg
Irbesartan 150mg

 

[Coaprovel®Tablet 300/12.5mg]
Hydrocholorothiazide 12.5mg
Irbesartan 300mg

Content

[Coaprovel®Tablet 150/12.5mg]
Oval film-coated tablet with a convex shape on both sides with pink color. One side is engraved with a heart shape, and the other side is marked with the number “2875”

[Coaprovel®Tablet 300/12.5mg]
Oval film-coated tablet with a convex shape on both sides with pink color. One side is engraved with a heart shape, and the other side is marked with the number “2876”

Indication

Essential hypertension
1. Patients not adequately controlled with monotherapy for hypertension
2. Initial therapy for patients, including those with moderate to severe hypertension (Stage 2), requiring combination therapy to achieve target blood pressure

Daonil Tab.

Ingredient

Glibenclamide

Content

5mg

Indication

Type 2 diabetes (limited to cases where sufficient effect cannot be achieved with diet and exercise)

Defitelio Inj. 200mg

Ingredient

Defibrotide

Content

200mg/2.5ml

Indication

Treatment of severe hepatic sinusoidal obstruction syndrome following hematopoietic stem cell transplant (HSCT).

Depakine Chrono Tab. 300mg

Ingredient

Sodium Valproate/Valproic Acid

Content

300mg

Indication

1) Prevention and treatment of epilepsy (absence seizure, tonic-clonic seizure, clonic seizures, psychomotor seizure, and mixed seizure) and personality disorder or behavioral disorder followed by epilepsy
2) Treatment of manic episodes associated with bipolar disorder
-In regard to manic episodes, safety and efficacy of this drug are not established for long-term use of 3 weeks or more. Therefore, a regular drug re-evaluation is needed for long-term drug use.